Cargando…
NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
The chemopreventive NO-donating NSAIDs (NO-NSAIDs; NSAIDs with an NO-releasing moiety) modulate PPARδ and offer the opportunity to revisit the controversial role of PPARδ in carcinogenesis (several papers report that PPARδ either promotes or inhibits cancer). This review summarizes the pharmacology...
Autores principales: | Mackenzie, Gerardo G., Rasheed, Shaheen, Wertheim, William, Rigas, Basil |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408682/ https://www.ncbi.nlm.nih.gov/pubmed/18528523 http://dx.doi.org/10.1155/2008/919572 |
Ejemplares similares
-
Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
por: Peters, Jeffrey M., et al.
Publicado: (2019) -
PPAR-δ in Vascular Pathophysiology
por: Wang, Nanping
Publicado: (2008) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008) -
Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
por: Higgins, Larry G., et al.
Publicado: (2012) -
Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology
por: Takayama, O, et al.
Publicado: (2006)